The development of dendritic cell vaccine-based immunotherapies for glioblastoma.

about

Immune Checkpoint Blockade Biology in Mouse Models of Glioblastoma.Immunotherapies for malignant glioma.Dendritic cells in autoimmunity, infections, and cancer.Novel Immunotherapeutics for the Treatment of Glioblastoma: The Last Decade of Research.

P2860

Q39147759-963BC8D7-03A9-4423-9FF4-8C318A35AC5B Q47915209-DF73594C-3CA3-4E7D-9A0A-E66E386C1B8B Q48348117-74F1C57F-DEE1-4F72-B983-B31AB7D7FD43 Q52564518-7C457C18-D79E-4C96-81BF-C1C20130A188

P2860

The development of dendritic cell vaccine-based immunotherapies for glioblastoma.

Item

http://www.wikidata.org/entity/Q38990679

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

The development of dendritic cell vaccine-based immunotherapies for glioblastoma.

@en

type

Item

label

The development of dendritic cell vaccine-based immunotherapies for glioblastoma.

@en

prefLabel

The development of dendritic cell vaccine-based immunotherapies for glioblastoma.

@en

P1476

The development of dendritic cell vaccine-based immunotherapies for glioblastoma.

@en

P2093

Duane A Mitchell

http://www.w3.org/2001/XMLSchema#string

P2860

Antigen presentation and T cell stimulation by dendritic cells

A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma

Consensus on the role of human cytomegalovirus in glioblastoma

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1

Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution

Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma

Immune Checkpoint Blockade in Cancer Therapy

Immunotherapy for primary brain tumors: no longer a matter of privilege

Structural and functional features of central nervous system lymphatic vessels.

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

P2888

s00281-016-0616-7

P304

225-239

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00281-016-0616-7

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

David A Reardon

P577

2017-01-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1074249844

http://www.w3.org/2001/XMLSchema#string

P698

28138787

http://www.w3.org/2001/XMLSchema#string

The development of dendritic cell vaccine-based immunotherapies for glioblastoma.

about

P2860

P2860

The development of dendritic cell vaccine-based immunotherapies for glioblastoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698